12:00 AM
 | 
Nov 23, 2009
 |  BC Week In Review  |  Company News  |  Deals

bioMerieux, GlaxoSmithKline deal

GlaxoSmithKline will co-fund bioMerieux's development of a pharmacogenetic test using undisclosed biomarkers for cancer. The CLIA test initially will be marketed by bioMerieux's...

Read the full 94 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >